Skip to content
Recall Observatory FDA recall evidence

Drug product

L-Cysteine Hydrochloride Injection, USP, 50 mg/mL, 50 mL Pharmacy Bulk Package Vials (NDC 66758-005-01), packaged in 5 x 50 mL Vials per carton(NDC 66758-005-02), Rx only, Manufactured for: Sandoz, Inc., Princeton, NJ.

D-0141-2017

November 09, 2016

Class II

Product summary

Firm
Sandoz Inc
Event
Event 75654
Status
Terminated
Classification
Class II
Quantity
33,624 vials
Official record key
drug-enforcement:D-0141-2017

Official wording

Reason: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.

Code information: Lot #: 2070915, 2071015, 2071415, 2071515, 2071615, 2071715, 2072115, 2072215, Exp 07/17; 2092315, 2093015, Exp 09/17; 2100115, Exp 10/17; 2120115, 2120215, Exp 12/17

Distribution pattern: Nationwide throughout the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility